Navigation Links
Marburg virus disease in Angola - update

As of 29 March 2005, the Ministry of Health has reported a total of 124 cases and 117 deaths in Cabinda, Luanda and Uige. All these cases had originated in Uige Province. Ten of these cases have been laboratory confirmed by the Centers for Disease Control and Prevention (CDC), Atlanta, USA.

The team from WHO, including experts from the Inter-country programme for southern Africa, the Regional Office for Africa (AFRO) and from Headquarters, and partners in the Global Outbreak Alert and Response Network (GOARN) are supporting the Ministry of Health, Angola to strengthen active surveillance and contact tracing.

Médecins sans Frontières (Belgium, France, Holland and Spain) are assisting with infection control and establishing isolation facilities in Uige hospital. Experts from the Department of Infectious Diseases, Manchester, United Kingdom and Johannesburg Hospital, South Africa are providing assistance in infection control in Luanda, where training will be provided for health care staff from all provinces in the country. The Canadian National Microbiology Laboratory will be setting up a mobile laboratory in Uige and CDC will be providing laboratory support in Luanda. UNICEF is carrying out social mobilization activities, raising awareness of the disease in the community and also providing additional logistic support and equipment.

Two travelers returning to Portugal from Angola were investigated for possible Marburg virus infection and laboratory results were negative in tests performed by the Bernard-Nocht Institute for Tropical Medicine, Hamburg, Germany, a WHO Reference Laboratory.


'"/>

Source:WHO


Page: 1

Related biology news :

1. Marburg haemorrhagic fever in Angola update
2. WHO suspends Marburg work, appeals for new funds
3. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
4. Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease
5. Association of herpesvirus with lung disorder questioned
6. Topical treatment shown to inhibit HIV and herpes simplex virus infection
7. Elusive HIV shape change revealed; Key clue to how virus infects cells
8. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
9. Live Recombinant Adenovirus Vaccine Technique Explored
10. Studies reveal methods viruses use to sidestep immune system
11. Norovirus, AIDS vaccine and Hepatitis Virus
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... , Dec. 6, 2016 Valencell , the ... it has seen a third consecutive year of triple ... technology in 2016 with a 360 percent increase in ... This increase was driven by sales of its wrist ... interest in its technology for hearables for fitness and ...
(Date:11/30/2016)... and WARSAW, Poland , Nov. 30, 2016 Not many ... of the most crucial aspects of recovery so we need to do it well. ... risks, including heart problems, high blood pressure, stroke, diabetes, and even cancer. ... and find a Christmas present that could help them to manage their sleep quality? ... ...
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... ... ... DuPont Industrial Biosciences (DuPont) and Archer Daniels Midland Company ... Platts Global Energy for their platform technology to produce a revolutionary biobased ... Platts Global Energy Awards, held in New York on Thursday, Dec. 8. , ...
(Date:12/9/2016)... , Dec. 9, 2016 /PRNewswire/ - Portage Biotech Inc. ... PBT.U), is pleased to announce that Biohaven has issued ... New Haven, Connecticut (PRWEB) Dec 9, 2016 ... "Biohaven") announced today that the U.S. Food and Drug ... request covering its drug candidate BHV-0223, an orally dissolving ...
(Date:12/8/2016)... Medical Incorporated ("OncoSec") (NASDAQ: ONCS ), ... announced financial results for the fiscal first quarter ... our commitment to address an unmet medical need ... with the early clinical response data presented from ... on advancing our lead program – ImmunoPulse® IL-12 ...
(Date:12/8/2016)... MOINES, Iowa , Dec. 8, 2016 Eurofins announces ... US Food and President of Eurofins Scientific Inc. (ESI). ... Division with his proven professional and entrepreneurial experience in leading international ... in the US food testing market to uphold Eurofins, status as ... ...
Breaking Biology Technology: